Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders: a Pilot Study

NCT02418273 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT02418273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02418273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders: a Pilot Study
Lead sponsor
Indiana University
Phase
Phase 1/2
Overall status
Withdrawn
Start date
August 1, 2019
Completion date
June 30, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis, glucocorticoid-induced osteoporosis, juvenile rheumatoid arthritis, osteoporosis, polyarthritis, systemic lupus erythematosis, vasculitis